Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry.
about
Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imagingComparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imagingCardiac PET perfusion: prognosis, risk stratification, and clinical managementClinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery diseaseNew SPECT and PET radiopharmaceuticals for imaging cardiovascular diseaseAdvanced tracers in PET imaging of cardiovascular diseaseClinical Utility and Future Applications of PET/CT and PET/CMR in Cardiology.Quantification of myocardial blood flow in absolute terms using (82)Rb PET imaging: the RUBY-10 Study.Acceptance of Combined Coronary CT Angiography and Myocardial CT Perfusion versus Conventional Coronary Angiography in Patients with Coronary Stents--Intraindividual Comparison.Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.Nuclear cardiology practice and associated radiation doses in Europe: results of the IAEA Nuclear Cardiology Protocols Study (INCAPS) for the 27 European countries.Coronary flow reserve from mouse to man--from mechanistic understanding to future interventions.Highly Sensitive Detection of Minimal Cardiac Ischemia using Positron Emission Tomography Imaging of Activated Platelets.Pet Imaging and its Application in Cardiovascular Diseases.Assessing the prognostic implications of myocardial perfusion studies: identification of patients at risk vs patients who may benefit from intervention?Quantification of myocardial blood flow using PET to improve the management of patients with stable ischemic coronary artery disease.Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence.Proceedings of the ASNC Cardiac PET Summit, 12 May 2014, Baltimore, MD : 1: The value of PET: Integrating cardiovascular PET into the care continuum.Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.Role of Fractional-Flow Reserve in Guiding Percutaneous Revascularization in Stable Coronary Artery Disease.Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations.Prognostic value of normal positron emission tomography myocardial perfusion imaging in patients with known or suspected coronary artery disease: a meta-analysis.Absolute quantification of myocardial blood flow.The role of positron emission tomography in the evaluation of myocardial ischemia in women.PET imaging in heart failure: the role of new tracers.Prognostic significance of blood pressure response during vasodilator stress Rb-82 positron emission tomography myocardial perfusion imaging.The impact of prompt gamma compensation on myocardial blood flow measurements with rubidium-82 dynamic PET.The role of nuclear cardiac imaging in risk stratification of sudden cardiac death.Use of observation followed by outpatient stress testing in chest pain patients with prior coronary artery disease history: An evaluation of prognostic utility.Prognostic value of positron emission tomography myocardial perfusion imaging beyond traditional cardiovascular risk factors: Systematic review and meta-analysis.Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease.Functional Information in Coronary Artery Disease: The Case of Computed Tomography Myocardial Perfusion.Prediction of clinical outcome by myocardial CT perfusion in patients with low-risk unstable angina pectoris.Interconnection of coronary macro- and microcirculation to each other: each component has relations that express all the others.Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD-PRO.Differential risk reclassification improvement by exercise testing and myocardial perfusion imaging in patients with suspected and known coronary artery disease.The Status of Stress Myocardial Perfusion Imaging Using 99mTc Pharmaceuticals in Japan: Results from a Nationwide Survey.SPECT but not PET remains as the working horse of the state of the art nuclear cardiac imaging laboratory: ConSemi-quantitative myocardial perfusion measured by computed tomography in patients with refractory angina: a head-to-head comparison with quantitative rubidium-82 positron emission tomography as reference
P2860
Q26825828-AEEF2C79-280E-4D73-B7B9-0CE58C503DF4Q26827495-16CE8BEE-2FBB-44B5-A4C8-5B96EE8721EFQ26852383-9F6D2A1C-E233-400C-82FA-66DAD7A4CCE8Q26859183-FF4EC4F6-D909-45D7-9E66-23A925F392A7Q27011866-D2BA4214-2DFC-4E39-B40F-6DA2A8473A9CQ27023690-170B4110-618A-4F29-9417-71196E0B48B9Q28073135-98FC311F-E361-4C73-98DE-F49EF8C93C69Q34660562-1158F81F-6E28-4E8C-8B3C-53CAD7CB547FQ35761082-77549829-7DF7-4CFC-ACED-A5A85D6B7401Q35921040-C4F0B2D7-A3C1-489D-83E2-BE75CAA115A2Q36610219-91E847D5-3021-438A-AE97-1F1D51902709Q37216087-56A28703-EAA6-4A95-B1C5-117849BE9DE6Q37464638-75DA2943-CE1F-4D70-99F2-0D66B082F520Q37743798-80A286FF-6917-48E4-A16B-97F4A091900CQ38192519-C382021E-54C3-4B7E-AEF1-DC1F8CF71AD6Q38263600-E3DC1CC6-B4E6-4612-AF59-B2C553AD9E39Q38432173-699C32DE-09B7-4F4D-88CF-4B0ECD9D379EQ38439405-E17CF67B-81BF-40E0-B317-9C67A6D1F214Q38480969-38A03673-A187-4CD3-A373-C062B8ED7012Q38552516-9BC13695-1139-46DD-AFE8-A4F35BF0BF2BQ38652030-E0E1A547-0973-4910-8E66-EC4908800F6BQ38741610-829E701C-2443-4E6E-80A1-6B70D4B71D60Q38901252-91D4AE88-327A-45DD-B00F-BBEE6A21A505Q38905038-77DA90B4-E6D8-4C4C-A2C7-C1F6A8B2E21AQ38917554-FCF07531-AD81-4578-80BD-9F02BBBFE856Q39285234-62442548-62FE-4875-AFA2-148488C44419Q39360519-3F4EC0E2-7E90-43AF-B58F-24CB12DD7A4AQ39394208-6827D4EE-698B-4DA5-9233-79502DDCF699Q39548660-218DF91F-92BF-4D51-870A-54CC267A8293Q40964313-567CBF6D-DD28-471C-9D1A-8F26815E4DB4Q40964410-C0B6183C-988F-40D3-A0F7-1C645579239DQ47410400-51BB4367-7A54-4B75-BD54-C5769EFA9103Q47876408-6AC8DDEA-0358-4C9C-8FD1-8CD238AD4DA7Q48314150-1A7986AF-D848-4BDF-B3DD-7E247CEC8E77Q49820811-39CCE0DB-98B3-49C4-A187-D158FEFBB831Q50497994-252FB401-8939-4554-A90E-78CD4B6DFF36Q52991032-CECF13E6-20F7-4C40-B19B-A5EBE89BBD0DQ55601885-7F3035C6-9215-4C0F-B1A9-7A003ED76EA2Q57621157-037B0B88-15DA-493D-BC18-CA4DAECBD2F0Q57680554-F1A0E3BF-70B6-41D8-BB61-EFA4391C36E7
P2860
Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prognostic value of stress myo ...... center observational registry.
@ast
Prognostic value of stress myo ...... center observational registry.
@en
type
label
Prognostic value of stress myo ...... center observational registry.
@ast
Prognostic value of stress myo ...... center observational registry.
@en
prefLabel
Prognostic value of stress myo ...... center observational registry.
@ast
Prognostic value of stress myo ...... center observational registry.
@en
P2093
P2860
P1476
Prognostic value of stress myo ...... center observational registry.
@en
P2093
Benjamin J W Chow
Brent A Williams
Daniel S Berman
Emir Veledar
James K Min
Leslee J Shaw
Marcelo F Di Carli
Michael E Merhige
Michael J Pencina
Rob S Beanlands
P2860
P304
P356
10.1016/J.JACC.2012.09.043
P407
P577
2012-12-05T00:00:00Z